D.E. Shaw & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,617
Closed -$397K 4850
2023
Q4
$308K Sell
1,617
-2,883
-64% -$545K ﹤0.01% 3741
2023
Q3
$896K Sell
4,500
-106,245
-96% -$25.1M ﹤0.01% 3128
2023
Q2
$31.6M Buy
110,745
+60,846
+122% +$16.9M 0.03% 619
2023
Q1
$10.8M Sell
49,899
-63,841
-56% -$12.4M 0.01% 1298
2022
Q4
$23.4M Buy
113,740
+25,335
+29% +$6.41M 0.03% 828
2022
Q3
$24.6M Buy
+88,405
New +$22.5M 0.03% 733
2022
Q2
Sell
-39,242
Closed -$8.14M 5902
2022
Q1
$8.14M Sell
39,242
-63,050
-62% -$10.4M 0.01% 1801
2021
Q4
$18.2M Sell
102,292
-51,799
-34% -$10.2M 0.02% 1148
2021
Q3
$31.7M Sell
154,091
-50,498
-25% -$9.91M 0.03% 757
2021
Q2
$38.8M Sell
204,589
-1,288
-0.6% -$211K 0.03% 669
2021
Q1
$26.8M Sell
205,877
-61,678
-23% -$7.4M 0.03% 775
2020
Q4
$27.8M Sell
267,555
-11,380
-4% -$986K 0.02% 793
2020
Q3
$21.1M Buy
278,935
+238,050
+582% +$13.5M 0.02% 800
2020
Q2
$1.94M Buy
+40,885
New +$1.68M ﹤0.01% 2432

Other funds holding SWAV

D.E. Shaw & Co's SWAV Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,617 shares — an estimated $397K sold.

D.E. Shaw & Co first reported a position in SWAV in Q2 2020 and held it in 14 quarters. The position peaked at $38.8M in Q2 2021. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,617 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $397K.
  • D.E. Shaw & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • D.E. Shaw & Co's Shockwave Medical, Inc. Common Stock position peaked at $38.8M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.